Pharmacy chain firms struggling to spark growth amid slump

Published: 2003-05-23 06:57:00

Updated: 2003-05-23 06:57:00

Overall, domestic pharmacy chain firms' first-quarter sales performance revealed the earlier-than-expected growth under the economic downturn and pharmaceutical slump, thanks to their endeavors to ignite a much-needed growth surge towards profitable IT business last year. Most of pharmacy chain f...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK